China Universal Asset Management Co., Ltd. Denali Therapeutics Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 26,721 shares of DNLI stock, worth $569,157. This represents 0.07% of its overall portfolio holdings.
Number of Shares
26,721
Previous 26,721
-0.0%
Holding current value
$569,157
Previous $548,000
-0.0%
% of portfolio
0.07%
Previous 0.07%
Shares
12 transactions
Others Institutions Holding DNLI
# of Institutions
217Shares Held
115MCall Options Held
142KPut Options Held
90.3K-
Baillie Gifford & CO14MShares$299 Million0.23% of portfolio
-
Black Rock Inc. New York, NY12.2MShares$260 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA11MShares$234 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA8.27MShares$176 Million0.03% of portfolio
-
State Street Corp Boston, MA6.32MShares$135 Million0.01% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $2.86B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...